Cooper JM - Search Results

1

A novel α-synuclein missense mutation in Parkinson disease.

Proukakis C, Dudzik CG, Brier T, MacKay DS, Cooper JM, Millhauser GL, Houlden H, Schapira AH. Proukakis C, et al. Among authors: cooper jm. Neurology. 2013 Mar 12;80(11):1062-4. doi: 10.1212/WNL.0b013e31828727ba. Epub 2013 Feb 20. Neurology. 2013. PMID: 23427326 Free PMC article.

2

Relationship between alpha synuclein phosphorylation, proteasomal inhibition and cell death: relevance to Parkinson's disease pathogenesis.

Chau KY, Ching HL, Schapira AH, Cooper JM. Chau KY, et al. Among authors: cooper jm. J Neurochem. 2009 Aug;110(3):1005-13. doi: 10.1111/j.1471-4159.2009.06191.x. Epub 2009 May 29. J Neurochem. 2009. PMID: 19493164 Free article.

3

Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains.

Gegg ME, Burke D, Heales SJ, Cooper JM, Hardy J, Wood NW, Schapira AH. Gegg ME, et al. Among authors: cooper jm. Ann Neurol. 2012 Sep;72(3):455-63. doi: 10.1002/ana.23614. Ann Neurol. 2012. PMID: 23034917 Free PMC article.

4

Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells.

McNeill A, Magalhaes J, Shen C, Chau KY, Hughes D, Mehta A, Foltynie T, Cooper JM, Abramov AY, Gegg M, Schapira AH. McNeill A, et al. Among authors: cooper jm. Brain. 2014 May;137(Pt 5):1481-95. doi: 10.1093/brain/awu020. Epub 2014 Feb 25. Brain. 2014. PMID: 24574503 Free PMC article.

5

Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease.

Gu M, Cooper JM, Taanman JW, Schapira AH. Gu M, et al. Among authors: cooper jm. Ann Neurol. 1998 Aug;44(2):177-86. doi: 10.1002/ana.410440207. Ann Neurol. 1998. PMID: 9708539

6

Proteasomal inhibition causes loss of nigral tyrosine hydroxylase neurons.

Schapira AH, Cleeter MW, Muddle JR, Workman JM, Cooper JM, King RH. Schapira AH, et al. Among authors: cooper jm. Ann Neurol. 2006 Aug;60(2):253-5. doi: 10.1002/ana.20934. Ann Neurol. 2006. PMID: 16862591

7

Chaperone-mediated autophagy markers in Parkinson disease brains.

Alvarez-Erviti L, Rodriguez-Oroz MC, Cooper JM, Caballero C, Ferrer I, Obeso JA, Schapira AH. Alvarez-Erviti L, et al. Among authors: cooper jm. Arch Neurol. 2010 Dec;67(12):1464-72. doi: 10.1001/archneurol.2010.198. Epub 2010 Aug 9. Arch Neurol. 2010. PMID: 20697033

8

Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission.

Alvarez-Erviti L, Seow Y, Schapira AH, Gardiner C, Sargent IL, Wood MJ, Cooper JM. Alvarez-Erviti L, et al. Among authors: cooper jm. Neurobiol Dis. 2011 Jun;42(3):360-7. doi: 10.1016/j.nbd.2011.01.029. Epub 2011 Feb 18. Neurobiol Dis. 2011. PMID: 21303699 Free PMC article.

9

Pramipexole reduces phosphorylation of α-synuclein at serine-129.

Chau KY, Cooper JM, Schapira AH. Chau KY, et al. Among authors: cooper jm. J Mol Neurosci. 2013 Oct;51(2):573-80. doi: 10.1007/s12031-013-0030-8. Epub 2013 May 18. J Mol Neurosci. 2013. PMID: 23681749 Free PMC article.

10

Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice.

Cooper JM, Wiklander PB, Nordin JZ, Al-Shawi R, Wood MJ, Vithlani M, Schapira AH, Simons JP, El-Andaloussi S, Alvarez-Erviti L. Cooper JM, et al. Mov Disord. 2014 Oct;29(12):1476-85. doi: 10.1002/mds.25978. Epub 2014 Aug 11. Mov Disord. 2014. PMID: 25112864 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

673 results

Search Page

Filters